Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir disoproxil fumarate vs placebo in adolescents with chronic hepatitis B
2007-003704-35Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Chronic Hepatitis B (CHB) comparing Tenofovir disoproxil fumarate with Placebo (2 arms). Primary endpoint: Composite virologic and biochemical response at Week 72. Started Jun 2008; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2007-003704-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003704-35.